- Home
- WRD vs PRCT Comparison
WRD vs PRCT Comparison
Compare WRD & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRD
- PRCT
- Stock Information
- Founded
- WRD 2017
- PRCT 2009
- Country
- WRD China
- PRCT United States
- Employees
- WRD N/A
- PRCT N/A
- Industry
- WRD
- PRCT Medical Specialities
- Sector
- WRD
- PRCT Health Care
- Exchange
- WRD NYSE
- PRCT Nasdaq
- Market Cap
- WRD 4.8B
- PRCT 5.3B
- IPO Year
- WRD 2024
- PRCT 2021
- Fundamental
- Price
- WRD $15.66
- PRCT $88.56
- Analyst Decision
- WRD Buy
- PRCT Strong Buy
- Analyst Count
- WRD 1
- PRCT 7
- Target Price
- WRD $23.00
- PRCT $97.86
- AVG Volume (30 Days)
- WRD 114.2K
- PRCT 475.4K
- Earning Date
- WRD 12-24-2024
- PRCT 10-28-2024
- Dividend Yield
- WRD N/A
- PRCT N/A
- EPS Growth
- WRD N/A
- PRCT N/A
- EPS
- WRD N/A
- PRCT N/A
- Revenue
- WRD $52,046,475.00
- PRCT $199,843,000.00
- Revenue This Year
- WRD N/A
- PRCT $67.07
- Revenue Next Year
- WRD N/A
- PRCT $40.64
- P/E Ratio
- WRD N/A
- PRCT N/A
- Revenue Growth
- WRD N/A
- PRCT 71.71
- 52 Week Low
- WRD $14.10
- PRCT $39.48
- 52 Week High
- WRD $22.69
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- WRD N/A
- PRCT 43.81
- Support Level
- WRD N/A
- PRCT $88.41
- Resistance Level
- WRD N/A
- PRCT $92.92
- Average True Range (ATR)
- WRD 0.00
- PRCT 3.84
- MACD
- WRD 0.00
- PRCT -1.29
- Stochastic Oscillator
- WRD 0.00
- PRCT 7.57
About WRD WERIDE INC. SPON ADS EACH REP 3 CL A ORD SHS
WeRide Inc operates in the autonomous driving industry. The company has developed a universal autonomous driving technology platform that integrates full-stack software algorithms, modularized hardware solutions, and a cloud-based infrastructure platform. The company provides autonomous driving products and services from L2 to L4 vehicles. The products of the company includes Robotaxi, Robobus, Robovan, Robosweeper, and others. The company earns its revenue from the People's Republic of China.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.